retatrutide expanded access compassionate use eli lilly granted to 79-year-old man via The retatrutide drug is manufactured
Description
For trainees and clinician-scientists, this is a reminder that therapeutic innovation and health economics are inseparable
But its hard to make coverage decisions based on theories
You are not doubling up on the same mechanism
The findings come as lawsuits are being filed nationwide, with plaintiffs alleging that manufacturers failed to adequately warn about the severity and persistence of certain digestive complications
